Pharmacology, Toxicology and Pharmaceutical Science
Muscarinic Receptor
90%
Pirenzepine
76%
Receptor Subtype
65%
Glucocorticoid Receptor
60%
Leporidae
57%
Disease
54%
Glucocorticoid
51%
Thrombocyte Activating Factor
43%
Dexamethasone
38%
Methacholine
30%
Emphysema
30%
Chronic Obstructive Lung Disease
30%
Receptor
26%
Binding Site
25%
Bronchoconstriction
24%
Muscarinic M1 Receptor
23%
Symptom
23%
Asthma
22%
Thrombocyte Activating Factor Receptor
21%
Bronchodilating Agent
21%
Isoniazid
20%
Tumor Necrosis Factor Receptor Superfamily Member 6
20%
Granulocyte Macrophage Colony Stimulating Factor
20%
Guanine Nucleotide Binding Protein
20%
Pertussis Toxin
20%
Deterioration
20%
Cardiovascular Disease
20%
Long Term Exposure
20%
Adrenergic Receptor Stimulating Agent
20%
Acquired Immune Deficiency Syndrome
20%
Guinea Pig
20%
Retinol
20%
Infection
20%
Respiratory Tract Disease
20%
Budesonide
20%
Intubation
20%
Almitrine Dimesilate
20%
Chemoprophylaxis
20%
Bleomycin
20%
Bradykinin
20%
Coccidioidomycosis
20%
Phosphatidylinositide
16%
Salbutamol
16%
Quinuclidinyl Benzilate
13%
Transcription Factor AP 1
13%
Alternative Complement Pathway C3 C5 Convertase
13%
Nuclear Factor
13%
Radioligand
12%
Cholinergic Receptor Stimulating Agent
10%
Muscarinic Receptor Blocking Agent
10%
Medicine and Dentistry
Intubation
100%
Intensive Care Unit
90%
Laryngoscopy
81%
Respiratory Physiology
60%
Smoking
41%
Disease
40%
Coccidioidomycosis
40%
Diffusing Capacity
30%
Chronic Obstructive Pulmonary Disease
30%
Elastic Recoil
30%
Respiratory Disease
26%
Cigarette Smoking
26%
Esophagus Intubation
22%
Difficult Airways
22%
Odds Ratio
22%
Bronchoalveolar Lavage Fluid
21%
Lung Function
21%
Lung Flow Volume Curve
20%
Deterioration
20%
Population
20%
Acquired Immune Deficiency Syndrome
20%
Density Dependence
20%
Noninvasive Positive Pressure Ventilation
20%
Neuromuscular Blocking
20%
Middle Age
20%
Bleomycin
20%
Symptom
20%
Isoniazid
20%
Diazepam
20%
Transbronchial Biopsy
20%
Flumazenil
20%
Retinol
20%
Neuromuscular Blocking Agent
20%
Platelet-Activating Factor
20%
Transcription Factor AP 1
20%
Chemoprophylaxis
20%
Prophylaxis
20%
Cytotechnology
20%
Screening Test
20%
Infection
20%
Intensive Care
20%
Forced Expiratory Volume
18%
Bronchodilating Agent
18%
Thrombocyte Activating Factor Receptor
17%
Airway Obstruction
16%
Human Immunodeficiency Virus Infection
13%
Prevalence
13%
Lung Volume
13%
Vital Capacity
13%
Asthma
12%
Keyphrases
Receptor Subtypes
60%
Platelet-activating Factor
42%
Glucocorticoid Receptor
40%
Subclinical Effects
40%
Methacholine
40%
Muscarinic Cholinergic Receptor
40%
Muscarinic Receptors
37%
Activator protein-1 (AP-1)
30%
Airway
29%
First Attempt Success
27%
Anti-inflammatory Effect
27%
Asthma
25%
Airway Epithelial Cells
25%
Bronchial Epithelial Cells
24%
Tracheal Smooth muscle
24%
Smokers
23%
Benzil
23%
Intubation Complications
22%
Peripheral Lung
22%
Epithelial Cell Line
21%
Platelet-activating Factor Receptor
21%
Pirenzepine
21%
Tissue Inflammation
20%
Granulocyte Colony-stimulating Factor (G-CSF)
20%
Primary Bronchial Epithelial Cells
20%
Transcriptional Mechanism
20%
Differential Control
20%
Eosinophil Survival
20%
Physiologic
20%
Accelerated Deterioration
20%
Physiological Test
20%
AIDS/HIV
20%
Non-smokers
20%
Respiratory Effects
20%
Tobacco Smoke
20%
Management Training Program
20%
Airway Management Training
20%
Glucocorticoid Signaling
20%
Noninvasive Positive Pressure Ventilation
20%
Atropine
20%
Propensity-matched Analysis
20%
Airway Response
20%
Coccidioidomycosis
20%
Tuberculosis
20%
Furosemide
20%
Fellowship Director
20%
Ultrasound Training
20%
Critical Care Ultrasound
20%
Hypoalbuminemia
20%
Diuretic Response
20%
